Literature DB >> 18483757

[Current diagnosis and treatment of migraine].

H-C Diener1, Z Katsarava, V Limmroth.   

Abstract

Headaches are one of the most common disorders and symptoms in daily medical practice. The prevalence of migraine is 8% in men and 12-15% in women. Dramatic progress in the areas of epidemiology, pathophysiology, and acute and preventive therapy of migraine has been made over the past 100 years, with triptans being the breakthrough for treating acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Nonpharmacologic treatment also plays an important role in migraine prevention. New medical care structures such as integrated headache care provide better support for patients with migraine, particularly those with chronic migraine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483757     DOI: 10.1007/s00347-008-1747-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  4 in total

Review 1.  [Migraine myths].

Authors:  H Wilhelm
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

2.  Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.

Authors:  E K Joseph; J D Levine
Journal:  Neuroscience       Date:  2012-12-20       Impact factor: 3.590

3.  A combinational effect of acetaminophen and oriental herbs on the regulation of inflammatory mediators in microglia cell line, BV2.

Authors:  Hyemin Kim; Seyeon Bae; Kil-Young Kwon; Young-Il Hwang; Jae Seung Kang; Wang Jae Lee
Journal:  Anat Cell Biol       Date:  2015-12-21

4.  Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).

Authors:  Otmar Bayer; Christine Adrion; Amani Al Tawil; Ulrich Mansmann; Michael Strupp
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.